Cargando…
Concerted Suppression of STAT3 and GSK3β Is Involved in Growth Inhibition of Non-Small Cell Lung Cancer by Xanthatin
Xanthatin, a sesquiterpene lactone purified from Xanthium strumarium L., possesses prominent anticancer activity. We found that disruption of GSK3β activity was essential for xanthatin to exert its anticancer properties in non-small cell lung cancer (NSCLC), concurrent with preferable suppression of...
Autores principales: | Tao, Li, Fan, Fangtian, Liu, Yuping, Li, Weidong, Zhang, Lei, Ruan, Junshan, Shen, Cunsi, Sheng, Xiaobo, Zhu, Zhijie, Wang, Aiyun, Chen, Wenxing, Huang, Shile, Lu, Yin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842975/ https://www.ncbi.nlm.nih.gov/pubmed/24312384 http://dx.doi.org/10.1371/journal.pone.0081945 |
Ejemplares similares
-
Xanthatin Induces Cell Cycle Arrest at G2/M Checkpoint and Apoptosis via Disrupting NF-κB Pathway in A549 Non-Small-Cell Lung Cancer Cells
por: Zhang, Lei, et al.
Publicado: (2012) -
Xanthatin inhibits STAT3 and NF‐κB signalling by covalently binding to JAK and IKK kinases
por: Liu, Man, et al.
Publicado: (2019) -
Xanthatin inhibits corneal neovascularization by inhibiting the VEGFR2-mediated STAT3/PI3K/Akt signaling pathway
por: Shen, Mei, et al.
Publicado: (2018) -
A Novel Nanoparticle Preparation to Enhance the Gastric Adhesion and Bioavailability of Xanthatin
por: Zhou, Yaqian, et al.
Publicado: (2020) -
Xanthatin synergizes with cisplatin to suppress homologous recombination through JAK2/STAT4/BARD1 axis in human NSCLC cells
por: Zhang, Jian, et al.
Publicado: (2021)